CERRONE GABRIELE M 4

What Happened
Gabriele M. Cerrone, a reported 10% owner of OKYO Pharma Ltd (OKYO), received a grant/award of 300,000 common shares on June 8, 2026. The shares were issued at $1.72 per share, for a total acquisition value of approximately $516,000. This transaction is an award/grant (transaction code A), meaning the insider acquired shares rather than sold them.

Key Details

• Transaction date: 2026-06-08. Filed with the SEC on 2026-06-10 (Accession: 0001493152-26-028117).
• Shares granted: 300,000 at $1.72 per share — total value ≈ $516,000.
• Transaction type: Award/Grant (code A).
• Insider status: Reported 10% owner.
• Shares owned after transaction: Not specified in the provided filing excerpt — see the full Form 4 for post-transaction holdings.
• Footnotes/tax withholding/10b5-1 plan: None reported in the provided excerpt.
• Filing timeliness: Form filed two days after the transaction date; no late-filing indicator noted in the excerpt.

Context
As a 10% owner, Cerrone is a significant shareholder; awards to large holders can come from compensation arrangements, conversion of instruments, or other corporate actions and do not necessarily indicate immediate intent to buy or sell in the open market. This was a direct grant of shares (not an option exercise or cashless sale); there is no indication in the excerpt that the shares were immediately sold. For full holdings and any explanatory footnotes, consult the complete Form 4 and related company disclosures.